RWJ-61907

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameRWJ-61907
Drug Alias NameRWJ-61907
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein kinases inhibitors
TargetsProtein kinases
Therapy Area/IndicationsEnterococcus faecium infectionsMycosesStaphylococcal Infections +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesRW Johnson Pharmaceutical Research Institute
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRW Johnson Pharmaceutical Research Institute
Active IndicationsN/A
Inactive IndicationsEnterococcus faecium infectionsMycosesStaphylococcal Infections +[4] 

Other Information

ATC CodeN/A
Related LinksN/A